These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 11435318

  • 1. Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions.
    Taylor PA, Lees CJ, Waldmann H, Noelle RJ, Blazar BR.
    Blood; 2001 Jul 15; 98(2):467-74. PubMed ID: 11435318
    [Abstract] [Full Text] [Related]

  • 2. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y, Luo B, Sozen H, Kalscheuer H, Blazar BR, Sutherland DE, Hering BJ, Guo Z.
    Transplantation; 2003 Jul 15; 76(1):216-24. PubMed ID: 12865813
    [Abstract] [Full Text] [Related]

  • 3. Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.
    Taylor PA, Lees CJ, Wilson JM, Ehrhardt MJ, Campbell MT, Noelle RJ, Blazar BR.
    Blood; 2002 Nov 01; 100(9):3400-7. PubMed ID: 12384443
    [Abstract] [Full Text] [Related]

  • 4. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H, Takeuchi Y, Shaffer J, Sykes M.
    Transplantation; 2006 Jul 27; 82(2):251-7. PubMed ID: 16858289
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY, Lee EN, Lee J, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Joh JW, Kim SJ.
    Exp Mol Med; 2006 Jun 30; 38(3):284-94. PubMed ID: 16819287
    [Abstract] [Full Text] [Related]

  • 7. Preconditioning of NOD mice with anti-CD8 mAb and costimulatory blockade enhances chimerism and tolerance and prevents diabetes, while depletion of alpha beta-TCR+ and CD4+ cells negates the effect.
    Ildstad ST, Chilton PM, Xu H, Domenick MA, Ray MB.
    Blood; 2005 Mar 15; 105(6):2577-84. PubMed ID: 15498851
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
    Gao D, Li J, Orosz CG, Bumgardner GL.
    Hepatology; 2000 Nov 15; 32(5):1018-28. PubMed ID: 11050052
    [Abstract] [Full Text] [Related]

  • 10. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX, Fan LY, Wang Q.
    Eur Surg Res; 2011 Nov 15; 46(3):109-17. PubMed ID: 21242693
    [Abstract] [Full Text] [Related]

  • 11. Strategic nonmyeloablative conditioning: CD154:CD40 costimulatory blockade at primary bone marrow transplantation promotes engraftment for secondary bone marrow transplantation after engraftment failure.
    Xu H, Huang Y, Chilton PM, Hussain LR, Tanner MK, Yan J, Ildstad ST.
    J Immunol; 2008 Nov 01; 181(9):6616-24. PubMed ID: 18941252
    [Abstract] [Full Text] [Related]

  • 12. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM, Gorechlad J, Larsen CP, Waller EK.
    Biol Blood Marrow Transplant; 2006 Dec 01; 12(12):1239-49. PubMed ID: 17162205
    [Abstract] [Full Text] [Related]

  • 13. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L, Li W, Zhong C, Qian S, Fung JJ, Thomson AW, Starzl TE.
    Transplantation; 1999 Sep 27; 68(6):747-57. PubMed ID: 10515374
    [Abstract] [Full Text] [Related]

  • 14. FTY720 markedly increases alloengraftment but does not eliminate host anti-donor T cells that cause graft rejection on its withdrawal.
    Taylor PA, Kelly RM, Bade ND, Smith MJ, Stefanski HE, Blazar BR.
    Biol Blood Marrow Transplant; 2012 Sep 27; 18(9):1341-52. PubMed ID: 22728248
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells.
    Kurtz J, Shaffer J, Lie A, Anosova N, Benichou G, Sykes M.
    Blood; 2004 Jun 01; 103(11):4336-43. PubMed ID: 14962909
    [Abstract] [Full Text] [Related]

  • 16. Earlier low-dose TBI or DST overcomes CD8+ T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40L.
    Takeuchi Y, Ito H, Kurtz J, Wekerle T, Ho L, Sykes M.
    Am J Transplant; 2004 Jan 01; 4(1):31-40. PubMed ID: 14678032
    [Abstract] [Full Text] [Related]

  • 17. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y, Sachs DH, Khan A, Sykes M.
    Transplantation; 1996 Feb 15; 61(3):469-77. PubMed ID: 8610363
    [Abstract] [Full Text] [Related]

  • 18. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.
    Wekerle T, Sayegh MH, Ito H, Hill J, Chandraker A, Pearson DA, Swenson KG, Zhao G, Sykes M.
    Transplantation; 1999 Nov 15; 68(9):1348-55. PubMed ID: 10573075
    [Abstract] [Full Text] [Related]

  • 19. Photochemical treatment of donor lymphocytes inhibited their ability to facilitate donor engraftment or increase donor chimerism after nonmyeloablative conditioning or establishment of mixed chimerism.
    Johnson BD, Taylor PA, Stankowski MC, Talib S, Hearst JE, Blazar BR.
    Biol Blood Marrow Transplant; 2002 Nov 15; 8(11):581-7. PubMed ID: 12463476
    [Abstract] [Full Text] [Related]

  • 20. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y, Meng L, Busuttil RW, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 2003 Mar 15; 170(6):3024-8. PubMed ID: 12626556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.